Skip to main content

Table 2 Experiment design and results of the Box–Behnken central composite design

From: Enhanced production of antifungal lipopeptide iturin A by Bacillus amyloliquefaciens LL3 through metabolic engineering and culture conditions optimization

Run order

Factors (g/l)

Titer (mg/l)

A

B

C

Experimental

Predicted

1

1

5

0.5

15.70 ± 4.21

15.11

2

13

5

0.5

52.87 ± 5.07

44.98

3

1

25

0.5

22.00 ± 3.14

29.88

4

13

25

0.5

51.58 ± 1.73

52.17

5

1

15

0.1

36.43 ± 0.28

34.91

6

13

15

0.1

54.03 ± 0.51

59.80

7

1

15

0.9

28.07 ± 2.02

22.30

8

13

15

0.9

48.05 ± 0.81

49.57

9

7

5

0.1

62.02 ± 3.64

64.14

10

7

25

0.1

72.06 ± 3.71

65.69

11

7

5

0.9

36.93 ± 6.77

43.29

12

7

25

0.9

65.81 ± 7.67

63.70

13

7

15

0.5

92.76

96.83

14

7

15

0.5

96.60

96.83

15

7

15

0.5

94.20

96.83

16

7

15

0.5

105.69

96.83

17

7

15

0.5

94.89

96.83